Ramus Seeking Quick Acceptance Of Rapidgraft In Coronary Bypass Market
This article was originally published in The Gray Sheet
Executive Summary
Ramus Medical Technologies, a start-up based in Santa Barbara, California, will conduct a 10-patient study of its Rapidgraft Arterial Vessel Substitute as a replacement for a patient's radial artery in the arm when that artery has been removed for use as a coronary artery bypass graft. The purpose is to generate data to support Rapidgraft's use as a replacement vessel in CABG procedures.